The PPARß/d-AMPK Connection in the Treatment of Insulin Resistance.
The current treatment options for type 2 diabetes mellitus do not adequately control the disease in many patients. Consequently, there is a need for new drugs to prevent and treat type 2 diabetes mellitus. Among the new potential pharmacological strategies, activators of peroxisome proliferator-acti...
| Autores: | , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2021 |
| País: | España |
| Institución: | Fundació Sant Joan de Déu |
| Repositorio: | r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu |
| OAI Identifier: | oai:fsjd.fundanetsuite.com:p19991 |
| Acceso en línea: | https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=19991 |
| Access Level: | acceso abierto |
| Palabra clave: | AMPK GDF15 PPARß/d insulin resistance type 2 diabetes mellitus |
| id |
ES_7f17185526d8742e073c3f0ebbfb3a00 |
|---|---|
| oai_identifier_str |
oai:fsjd.fundanetsuite.com:p19991 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
The PPARß/d-AMPK Connection in the Treatment of Insulin Resistance.Aguilar-Recarte DPalomer XWahli WVázquez-Carrera MAMPKGDF15PPARß/dinsulin resistancetype 2 diabetes mellitusThe current treatment options for type 2 diabetes mellitus do not adequately control the disease in many patients. Consequently, there is a need for new drugs to prevent and treat type 2 diabetes mellitus. Among the new potential pharmacological strategies, activators of peroxisome proliferator-activated receptor (PPAR)ß/d show promise. Remarkably, most of the antidiabetic effects of PPARß/d agonists involve AMP-activated protein kinase (AMPK) activation. This review summarizes the recent mechanistic insights into the antidiabetic effects of the PPARß/d-AMPK pathway, including the upregulation of glucose uptake, muscle remodeling, enhanced fatty acid oxidation, and autophagy, as well as the inhibition of endoplasmic reticulum stress and inflammation. A better understanding of the mechanisms underlying the effects resulting from the PPARß/d-AMPK pathway may provide the basis for the development of new therapies in the prevention and treatment of insulin resistance and type 2 diabetes mellitus.MDPI2021info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=19991INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESISSN: 16616596ISSNe: 14220067reponame:r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déuinstname:Fundació Sant Joan de DéuInglésinfo:eu-repo/semantics/openAccessoai:fsjd.fundanetsuite.com:p199912026-05-27T12:37:41Z |
| dc.title.none.fl_str_mv |
The PPARß/d-AMPK Connection in the Treatment of Insulin Resistance. |
| title |
The PPARß/d-AMPK Connection in the Treatment of Insulin Resistance. |
| spellingShingle |
The PPARß/d-AMPK Connection in the Treatment of Insulin Resistance. Aguilar-Recarte D AMPK GDF15 PPARß/d insulin resistance type 2 diabetes mellitus |
| title_short |
The PPARß/d-AMPK Connection in the Treatment of Insulin Resistance. |
| title_full |
The PPARß/d-AMPK Connection in the Treatment of Insulin Resistance. |
| title_fullStr |
The PPARß/d-AMPK Connection in the Treatment of Insulin Resistance. |
| title_full_unstemmed |
The PPARß/d-AMPK Connection in the Treatment of Insulin Resistance. |
| title_sort |
The PPARß/d-AMPK Connection in the Treatment of Insulin Resistance. |
| dc.creator.none.fl_str_mv |
Aguilar-Recarte D Palomer X Wahli W Vázquez-Carrera M |
| author |
Aguilar-Recarte D |
| author_facet |
Aguilar-Recarte D Palomer X Wahli W Vázquez-Carrera M |
| author_role |
author |
| author2 |
Palomer X Wahli W Vázquez-Carrera M |
| author2_role |
author author author |
| dc.subject.none.fl_str_mv |
AMPK GDF15 PPARß/d insulin resistance type 2 diabetes mellitus |
| topic |
AMPK GDF15 PPARß/d insulin resistance type 2 diabetes mellitus |
| description |
The current treatment options for type 2 diabetes mellitus do not adequately control the disease in many patients. Consequently, there is a need for new drugs to prevent and treat type 2 diabetes mellitus. Among the new potential pharmacological strategies, activators of peroxisome proliferator-activated receptor (PPAR)ß/d show promise. Remarkably, most of the antidiabetic effects of PPARß/d agonists involve AMP-activated protein kinase (AMPK) activation. This review summarizes the recent mechanistic insights into the antidiabetic effects of the PPARß/d-AMPK pathway, including the upregulation of glucose uptake, muscle remodeling, enhanced fatty acid oxidation, and autophagy, as well as the inhibition of endoplasmic reticulum stress and inflammation. A better understanding of the mechanisms underlying the effects resulting from the PPARß/d-AMPK pathway may provide the basis for the development of new therapies in the prevention and treatment of insulin resistance and type 2 diabetes mellitus. |
| publishDate |
2021 |
| dc.date.none.fl_str_mv |
2021 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=19991 |
| url |
https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=19991 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
MDPI |
| publisher.none.fl_str_mv |
MDPI |
| dc.source.none.fl_str_mv |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES ISSN: 16616596 ISSNe: 14220067 reponame:r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu instname:Fundació Sant Joan de Déu |
| instname_str |
Fundació Sant Joan de Déu |
| reponame_str |
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu |
| collection |
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869411798356066304 |
| score |
15,81155 |